04Mar 2021
Revealing the BRD4-NOTCH3 fusion: a novel hill in the cancer landscape

Revealing the BRD4-NOTCH3 fusion: a novel hill in the cancer landscape

Transcript fusions have long been associated with cancer development. The recent use of comprehensive DNA/RNA sequencing in the cancer scenario has uncovered fusions that, today, are seen as optimal targets for personalized medicine, such as those involving genes ALK, FGFR and NTRK. The most frequent cancer driver fusions emerged from data cohorts such as TCGA consortium.

  • #pulmonology

Like

Save

Share